Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.
about
Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@en
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@nl
type
label
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@en
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@nl
prefLabel
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@en
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Sclareolide enhances gemcitabi ...... stant human pancreatic cancer.
@en
P2093
Jian-Hua Zhang
Mao-Sheng Dong
Sheng Chen
Wen-Long Zhang
P2860
P304
P356
10.3892/MMR.2017.6182
P577
2017-02-08T00:00:00Z